About Shionogi Shionogi was founded in 1878 in Osaka, Japan where our headquarters remain. The company has grown to become a major research-driven pharmaceutical company dedicated to placing the highest value on patient care. Shionogi has a strong heritage in the discovery and development of globally important therapies. Shionogi & Co., Ltd has recently launched its new European Headquarters, Shionogi Limited in London. Establishing the new headquarters is an important milestone for the Company as it further expands the organisation into the global arena. Shionogi Limited (SL) will serve as a hub for development and drive the management of new innovative medicines across Europe, as well as the Middle East and Africa. SL aspires to be at the forefront of areas within our focus and push the boundaries of science and the way we work.